Description
| Method: | CMIA, EIA |
| Comment: | |
| Price: | 3500.00 |
| Report: | Sample Mon by 9 am; Report Same day |
| Usage: | Ovarian cancer is classified into three types: Epithelial (80%), Germ cell tumor (10-15%) & Stromal sex cord tumors (5-10%). Epithelial ovarian tumors are further subdivided into serous (70%), mucinous(10-15%) and endometroid (10-15%). Granulosa cell tumors represent the majority of the Stromal sex cord tumor. CA 125 is elevated in 50% of patients with stage I ovarian cancer, 90% with stage II and > 90% in stage III & IV. CA 125 is not a good tumor marker for Mucinous & Granulosa cell tumors. Inhibin B is a useful tumor marker for these two malignancies. Inhibin B elevation has been reported in 89-100% of patients with Granulosa cell tumors & 55-60% of patients with Mucinous Epithelial tumors. |
| Doctor Specialty: | Oncologist |
| Disease: | Cancer |
| Components: | *CA 125 *Alpha feto protein (afp), Beta hcg,Ca-125, Ca 15.3, Ca 19.9, Carcino embryonic antigen (cea) |
| Courier Charges: | 0.00 |
| Home Collection: | Available |
| Department: | |
| Pre Test Information: | No special preparation required |